Is MRRL or JNJ a better dividend investment in 2026?

MRRL currently yields 952.38% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: MRRL offers higher current income.

What is the dividend yield difference between MRRL and JNJ?

MRRL has a forward dividend yield of 952.38% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 949.02 percentage points.

Home › Compare › MRRL vs JNJ

MRRL vs JNJ: Dividend Comparison 2026

MRRL yields 952.38% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MRRL wins by $12332448.59M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MRRL

● Live price

952.38%

Share price

$0.21

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$12332448.61M

Annual income

$10,221,241,957,700.52

Full MRRL calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — MRRL vs JNJ

📍 MRRL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MRRL	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MRRL + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MRRL pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRRL

Annual income on $10K today (after 15% tax)

$80,952.38/yr

After 10yr DRIP, annual income (after tax)

$8,688,055,664,045.44/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, MRRL beats the other by $8,688,055,663,341.83/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRRL + JNJ for your $10,000?

MRRL: 50%JNJ: 50%

100% JNJ50/50100% MRRL

Portfolio after 10yr

$6166224.31M

Annual income

$5,110,620,979,264.15/yr

Blended yield

82.88%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MRRL

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRRL buys

JNJ buys

No recent congressional trades found for MRRL or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMRRLJNJ

Forward yield	952.38% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$12332448.61M ✓	$20.0K
Annual income after 10y	$10,221,241,957,700.52 ✓	$827.78
Total dividends collected	$12170002.88M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MRRL vs JNJ ($10,000, DRIP)

Year	MRRL Portfolio	MRRL Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$105,938	$95,238.10	$10,676	$355.77	+$95.3K → MRRL
2	$1,056,283	$942,929.20	$11,407	$389.39	+$1.04M → MRRL
3	$9,916,875	$8,786,651.85	$12,198	$426.53	+$9.90M → MRRL
4	$87,707,472	$77,096,416.11	$13,056	$467.62	+$87.69M → MRRL
5	$731,100,427	$637,253,432.49	$13,987	$513.12	+$731.09M → MRRL
6	$5,746,701,273	$4,964,423,815.28	$14,998	$563.56	+$5746.69M → MRRL
7	$42,618,205,654	$36,469,235,291.84	$16,098	$619.52	+$42618.19M → MRRL
8	$298,367,923,577	$252,766,443,527.28	$17,295	$681.69	+$298367.91M → MRRL
9	$1,973,090,326,149	$1,653,836,647,921.55	$18,599	$750.82	+$1973090.31M → MRRL
10	$12,332,448,606,679	$10,221,241,957,700.52	$20,022	$827.78	+$12332448.59M → MRRL

MRRL vs JNJ: Complete Analysis 2026

MRRL — Stock

The investment seeks a return linked to the Market VectorsÂ Global Mortgage REITs Index. The ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN Series B due October 16, 2042 is a series of Monthly Pay 2xLeveraged ETRACS. The index tracks the overall performance of publicly-traded mortgage REITs that derive at least 50% of their revenues from mortgage-related activities. The Securities are senior unsecured debt securities issued by UBS AG. The Securities are two times leveraged with respect to the index, and, as a result, will benefit from two times any positive, but will be exposed to two times any negative, compounded monthly performance of the index.

Full MRRL Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this MRRL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRRL vs SCHD MRRL vs JEPI MRRL vs O MRRL vs KO MRRL vs MAIN MRRL vs ABBV MRRL vs MRK MRRL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.